Treatment strategy of the HER 2 positive breast cancer with CNS metastases.
Belohorska
B
B
Ist Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Svec
J
J
Vertakova-Krakovska
B
B
Tkacova
M
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology*; D016543:Central Nervous System Neoplasms / Q000556:secondary*; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab